Unraveling amyloid toxicity pathway in NIH3T3 cells by a combined proteomic and 1H-NMR metabonomic approach

Journal of Cellular Physiology

Volumn 228, Issue 6, 2013, Pages 1359-1367

  Vilasi, Annalisa ^a   Vilasi, Silvia ^b   Romano, Rocco ^c   Acernese, Fausto ^c   Barone, Fabrizio ^c   Balestrieri, Maria Luisa ^d   Maritato, Rosa ^d   Irace, Gaetano ^d,e   Sirangelo, Ivana ^d,e  

^a INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

^d SECOND UNIVERSITY OF NAPLES   (Italy)

^e NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMYLOID; APOMYOGLOBIN; CREATINE PHOSPHATE; GLUTAMIC ACID; LEUCINE; N ACETYLASPARTIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHORYLCHOLINE; PROTEIN DISULFIDE ISOMERASE; SUCCINIC ACID;

ANIMAL CELL; ARTICLE; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEMBRANE DAMAGE; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; PROTON NUCLEAR MAGNETIC RESONANCE; RUMINANT STOMACH; STRUCTURAL PROTEOMICS; TOXICITY;

EID: 84874203299     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24294     Document Type: Article

References (72)

1. Bains JS, Shaw CA. 1997. Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death. Brain Res 25:335-358.
2. Batandier C, Guigas B, Detaille D, El-Mir MY, Fontaine E, Rigoulet M, Leverve XM. 2006. The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin. J Bioenerg Biomembr 38:33-42.
3. Beetsch JW, Olson JE. 1998. Taurine synthesis and cysteine metabolism in cultured rat astrocytes: Effects of hyperosmotic exposure. Am J Physiol 274:C866-C874.
4. Bixel MG, Engelmann J, Willker W, Hamprecht B, Leibfritz D. 2004. Metabolism of [U-(13)C] leucine in cultured astroglial cells. Neurochem Res 29:2057-2067.
5. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507-511.
6. Bucciantini M, Rigacci S, Berti A, Pieri L, Cecchi C, Nosi D, Formigli L, Chiti F, Stefani M. 2005. Patterns of cell death triggered in two different cell lines by HypF-N prefibrillar aggregates. FASEB J 19:437-439.
7. Candé C, Vahsen N, Kouranti I, Schmitt E, Daugas E, Spahr C, Luban J, Kroemer RT, Giordanetto F, Garrido C, Penninger JM, Kroemer G. 2004. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 23:1514-1521.
8. Carrell RW, Lomas DA. 1997. Conformational disease. Lancet 350:134-138.
9. Chen JG, Charles HC, Barboriak D, Doraiswamy PM. 2000. Magnetic resonance spectroscopy in Alzheimer's disease: Focus on N-acetylaspartate. Acta Neurol Scand Suppl 176:20-26.
10. Chiti F, Webster P, Taddei N, Clark A, Stefani M, Ramponi G, Dobson CM. 1999. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 96:3590-3594.
11. Circu ML, Aw TY. 2008. Gluthatione and apoptosis. Free Radic Res 42:689-706.
12. Dobson CM. 2001. The structural basis of protein folding and its links with human disease. Philos Trans R Soc London B Biol Sci 356:133-145.
13. Dobson CM. 2003. Protein folding and misfolding. Nature 426:884-890.
14. Fandrich M, Fletcher MA, Dobson CM. 2001. Amyloid fibrils from muscle myoglobin. Nature 410:165-166.
15. Foldi I, Datki ZL, Szabo Z, Bozso Z, Penke B, Janaky T. 2011. Proteomic study of the toxic effect of oligomeric Aβ1-42 in situ prepared from 'iso-Aβ1-42'. J Neurochem 117:691-702.
16. Friesen C, Kiess Y, Debatin KM. 2004. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells. Cell Death Differ 11:S73-S85.
17. Han J, Sun P. 2007. The pathways to tumor suppression via route p38. Trends Biochem Sci 32:364-371.
18. Huang DW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat Protoc 4:44-57.
19. Infusini G, Iannuzzi C, Vilasi S, Birolo L, Pagnozzi D, Pucci P, Irace G, Sirangelo I. 2012. Resolution of the effects induced by W→F substitutions on the conformation and dynamics of the amyloid-forming apomyoglobin mutant W7FW14F. Eur Biophys J 41:615-627.
20. Joerchel S, Raap M, Bigl M, Eschrich K, Schliebs R. 2008. Oligomeric beta-amyloid(1-42) induces the expression of Alzheimer disease-relevant proteins in cholinergic SN56.B5.G4 cells as revealed by proteomic analysis. Int J Dev Neurosci 26:301-308.
21. Jovanovic P, Zoric L, Stefanovic I, Dzunic B, Djordjevic-Jocic J, Radenkovic M, Jovanovic M, Bosn J. 2010. Lactate dehydrogenase and oxidative stress activity in primary open-angle glaucoma aqueous humour. Basic Med Sci 10:83-88.
22. Kaneko I, Yamada N, Sakuraba Y, Kamenosono M, Tutumi S. 1995. Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue. J Neurochem 65:2585-2593.
23. 1H NMR studies of the reactions of copper(I) and copper(II) with D-penicillamine and glutathione. J Inorg Biochem 75:117-121.
24. Khaitlina SY. 2001. Functional specificity of actin isoforms. Int Rev Cytol 202:35-98.
25. Kourie JI. 2001. Mechanisms of amyloid beta protein-induced modification in ion transport systems: Implications for neurodegenerative diseases. Cell Mol Neurobiol 21:173-213.
26. Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE. 1998. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci 95:6448-6453.
27. Lanius RA, Krieger C, Wagey R, Shaw CA. 1993. Increased [35S] glutathione binding sites in spinal cords from patients with sporadic amyotrophic lateral sclerosis. Neurosci Lett 163:89-92.
28. Lansbury PT. 1999. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci USA 96:3342-3344.
29. Lemmerling P, Vanhamme L, Romano R, Van Huffel S. 2002. A subspace time domain algorithm for automated NMR spectral normalization. J Magn Reson 157:190-199.
30. 2+ increases and cell death. J Biol Chem 273:12858-12862.
31. Lu C, Armstrong JS. 2007. Role of calcium and cyclophilin D in the regulation of mitochondrial permeabilization induced by glutathione depletion. Biochem Biophys Res Commun 363:572-577.
32. Magherini F, Pieri L, Guidi F, Giangrande C, Amoresano A, Bucciantini M, Stefani M, Modesti A. 2009. Proteomic analysis of cells exposed to prefibrillar aggregates of HypF-N. Biochimica et Biophysica Acta 1794:1243-1250.
33. Marcinkiewicz J, Grabowska A, Bereta J, Stelmaszynska T. 1995. Taurine chloramine, a product of activated neutrophils, inhibits in vitro generation of nitric oxide and other macrophagein flammatory mediator. J Leukoc Biol 58:667-674.
34. Merad-Boudia M, Nicole A, Santiard-Baron D, Saille C, Ceballos-Picot I. 1998. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: Relevance to Parkinson's disease. Biochem Pharmacol 56:645-655.
35. Merlini G, Bellotti V. 2003. Molecular mechanisms of amyloidosis. N Engl J Med 349:583-596.
36. Milhavet O, Lehmann S. 2002. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res Rev 38:328-339.
37. Na KS, Park BC, Jang M, Cho S, Lee do H, Kang S, Lee CK, Bae KH, Park SG. 2007. Protein disulfide isomerase is cleaved by caspase-3 and -7 during apoptosis. Mol Cells 24:261-267.
38. Nilsberth C, Westlin-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Naslund J, Lannfelt L. 2001. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci 4:887-893.
39. O'Farrell PH. 1975. High-resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007-4021.
40. Ortore MG, Spinozzi F, Vilasi S, Sirangelo I, Irace G, Shukla A, Narayanan T, Sinibaldi R, Mariani P. 2011. Time-resolved small-angle x-ray scattering study of the early stage of amyloid formation of an apomyoglobin mutant. Phys Rev E Stat Nonlin Soft Matter Phys 84:061904.
41. Rainaldi G, Romano R, Indovina P, Ferrante A, Motta A, Indovina PL, Santini MT. 2008. Metabolomics using 1H-NMR of apoptosis and Necrosis in HL60 leukemia cells: Differences between the two types of cell death and independence from the stimulus of apoptosis used. Radiat Res 169:170-180.
42. Reddy RK, Lu J, Lee AS. 1999. The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca(2+)-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis. J Biol Chem 274:28476-28483.
43. Redondo PC, Salido GM, Rosado JA, Pariente JA. 2004. Effect of hydrogen peroxide on Ca2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms. Biochem Pharmacol 67:491-502.
44. Riedere P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MB. 1989. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52:515-520.
45. Romano R, Lamanna R, Santini MT, Indovina PL. 1999. A new algorithm for NMR spectral normalization. J Magn Reson 138:115-122.
46. Romano R, Motta A, Camassa S, Pagano C, Santini MT, Indovina PL. 2002. A new time-domain frequency-selective quantification algorithm. J Magn Reson 155:226-235.
47. Ross SM. 1987. Introduction to probability and statistics for engineers and scientists. New York: John Wiley and Sons, Inc. pp. 62-63.
48. 1H NMR study. FEBS Lett 557:148-154.
49. Santini MT, Rainaldi G, Ferrante A, Romano R, Clemente S, Motta A, De Berardis B, Balduzzi M, Paoletti L, Indovina PL. 2004b. Environmental fine particulate matter (PM 2.5) activates the RAW 264.7 macrophage cell line even at very low concentrations as revealed by 1H NMR. Chem Res Toxicol 17:63-74.
50. Santini MT, Romano R, Rainaldi G, Indovina P, Ferrante A, Motta A, Indovina PL. 2006. Temporal dynamics of 1H-NMR-visible metabolites during radiation-induced apoptosis in MG-63 human osteosarcoma spheroids. Radiat Res 166:734-745.
51. Satoh K, Shimokawa H, Berk BC. 2010. Cyclophilin A: Promising new target in cardiovascular therapy. Circ J 74:2249-2256.
52. Sirangelo I, Irace G. 2010. Inhibition of aggregate formation as therapeutic target in protein misfolding diseases: Effect of tetracycline and trehalose. Expert Opin Ther Targets 14:1311-1321.
53. Sirangelo I, Malmo C, Casillo MT, Mezzogiorno A, Papa M, Irace G. 2002. Tryptophanyl substitutions in apomyoglobin determine protein aggregation and amyloid-like fibril formation at physiological pH. J Biol Chem 277:45887-45891.
54. Sirangelo I, Malmo C, Iannuzzi C, Mezzogiorno A, Bianco MR, Papa M, Irace G. 2004. Fibrillogenesis and cytotoxic activity of the amyloid-forming apomyoglobin mutant W7FW14F. J Biol Chem 279:13183-13189.
55. Sirangelo I, Iannuzzi C, Vilasi S, Irace G, Giuberti G, Misso G, D'Alessandro A, Abbruzzese A, Caraglia M. 2009. W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac. J Cell Physiol 221:412-423.
56. Sorrentino A, Giosafatto CV, Sirangelo I, De Simone C, Di Pierro P, Porta R, Mariniello L. 2012. Higher susceptibility to amyloid fibril formation of the recombinant ovine prion protein modified by transglutaminase. Biochim Biophys Acta 1822:1509-1515.
57. Stefani M. 2004. Protein misfolding and aggregation: New examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta 1739:5-25.
58. Stefani M, Dobson CM. 2003. Protein aggregation and aggregate toxicity: New insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81:678-699.
59. Sunde M, Blake C. 1997. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv Protein Chem 50:123-159.
60. Sunde M, Blake CC. 1998. From the globular to the fibrous state: Protein structure and structural conversion in amyloid formation. Q Rev Biophys 31:1-39.
61. Tiefenthaler M, Amberger A, Bacher N, Hartmann BL, Margreiter R, Kofler R, Konwalinka G. 2001. Increased lactate production follows loss of mitochondrial membrane potential during apoptosis of human leukaemia cell. Br J Haematol 114:574-580.
62. Van PN, Peter F, Söling HD. 1989. Four intracisternal calcium-binding glycoproteins from rat liver microsomes with high affinity for calcium. No indication for calsequestrin-like proteins in inositol 1, 4, 5-trisphosphate-sensitive calcium sequestering rat liver vesicles. J Biol Chem 264:17494-17501.
63. Vandermoere F, El Yazidi-Belkoura I, Slomianny C, Demont Y, Bidaux G, Adriaenssens E, Lemoine J, Hondermarck H. 2006. The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival. J Biol Chem 281:14307-14313.
64. Vilasi A, Cutillas PR, Maher AD, Zirah SF, Capasso G, Norden AW, Holmes E, Nicholson JK, Unwin RJ. 2007. Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. Am J Physiol Renal Physiol 293:F456-F467.
65. Vilasi A, Cutillas PR, Unwin RJ. 2008a. Application of proteomic techniques to the study of urine and renal tissue. Proteomics Clin Appl 2:1564-1574.
66. Vilasi S, Iannuzzi C, Portaccio M, Irace G, Sirangelo I. 2008b. Effect of trehalose on W7FW14F apomyoglobin and insulin fibrillization: New insight into inhibition activity. Biochemistry 47:1789-1796.
67. Vilasi S, Sirangelo I, Irace G, Caputo I, Barone MV, Esposito C, Ragone R. 2010. Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment. J Mol Recognit 23:322-328.
68. Vilasi S, Sarcina R, Maritato R, De Simone A, Irace G, Sirangelo I. 2011. Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro. PLoS ONE 6:e22076.
69. Watson RW, Rotstein OD, Jimenez M, Parodo J, Marshall JC. 1997. Augmented intracellular glutathione inhibits Fas-triggered apoptosis of activated human neutrophils. Blood 89:4175-4181.
70. Woltjer RL, Nghiem W, Maezawa I, Milatovic D, Vaisar T, Montine KS, Montine TJ. 2005. Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity. J Neurochem 93:1047-1056.
71. Zhengyu L, Xia Z, Shujun B, Zhi W, Lijuan C, Yuquan W, Canhua H. 2008. Proteomics identification of cyclophilin A as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics 7:1810-1823.
72. Zhu C, Wang X, Deinum J, Huang Z, Gao J, Modjtahedi N, Neagu MR, Nilsson M, Eriksson PS, Hagberg H, Luban J, Kroemer G, Blomgren K. 2007. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med 204:1741-1748.